A functional study on prostanoid receptors involved in cultured human iridal melanocyte stimulation

Experimental Eye Research

Volumn 73, Issue 1, 2001, Pages 93-100

  Hu, Dan Ning ^a,b   M C Cormick, Steven A ^a,b   Woodward, David F ^c  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

^c ALLERGAN INC   (United States)

Author keywords

D P receptors; EP1 receptors; EP2 receptors; EP3 receptors; EP4 receptors; IP receptors; Iridal melanocytes; Prostaglandin D2; Prostaglandin E2; Prostanoid; TP receptors

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 2 [4 (1 HYDROXYHEXYL)PHENYL] 5 OXOCYCLOPENTANEHEPTANOIC ACID; 3 BENZYL 5 (6 CARBOXYHEXYL) 1 (2 CYCLOHEXYL 2 HYDROXYETHYLAMINO)HYDANTOIN; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; 7 [7 (3 HYDROXY 1 OCTENYL) 3 OXO 2,4 DIOXABICYCLO[3.2.1]OCT 6 YL] 5 HEPTENOL; BASIC FIBROBLAST GROWTH FACTOR; CICAPROST; CYCLIC AMP; ILOPROST; MELANIN; ONO AE1 329; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTANOID; PROSTANOID RECEPTOR; SULPROSTONE; THROMBOXANE; UNCLASSIFIED DRUG;

ARTICLE; CELL CULTURE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DENDRITE; HUMAN; HUMAN CELL; IRIS; MELANOCYTE; MELANOGENESIS; PRIORITY JOURNAL; SECOND MESSENGER;

EID: 0034769544     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.2001.1011     Document Type: Article

References (37)

1. Intraocular pressure-reducing effect of PhXA41 in patients with increased eye pressure. A one-month study
2. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat and monkey eyes
3. Reduction of intraocular pressure by prostaglandins applied topically to the eyes of conscious rabbits
4. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma. A six-month, masked, multicenter trial in the United States
5. VIII. International Union of Pharmacology classification of prostanoid receptors: Properties, distribution and structure of the receptors and their subtypes
6. Prostaglandin E2 binding sites in human renal tissue: Characterization and localization by radioligand binding and autoradiography
7. 2 is a ligand for the adipocyte determination factor PPAR gamma
8. The classification of prostaglandin DP-receptors in platelets and vasculature using BW A868C, a novel, selective and potent competitive antagonist
9. Regulation of human melanocytes growth, dendricity, and melanization by keratinocytes derived factors
10. 2α 1-isopropyl ester vs. iloprost phenacyl ester in rabbit and beagle eyes
11. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane CRTH2
12. Regulation of melanogenesis by human uveal melanocytes in vitro
13. Studies of human uveal melanocytes in vitro: Growth regulation of cultured human uveal melanocytes
14. Studies of human uveal melanocytes in vitro: Isolation, purification and cultivation of human uveal melanocytes
15. 2α and latanoprost on cultured iridial mlanocytes
16. Pharmacological evidence for thromboxane receptor heterogeneity-implications for the eye
17. 2α
18. Increased pigmentation of iridial melanocytes in primates induced by a prostaglandin analogue
19. 2 and its analogue, BW 245C, on intraocular pressure in humans
20. 2 receptor agonist
21. 2 but not MSH stimulate the proliferation of pigment cells in the pinnal epidermis of the DBA/2 mouse
22. 2 subtype
23. 4 subtype selective agonist, ONO-AE1-329
24. Prostaglandin-induced iridial pigmentation in primates
25. Mechanism and clinical significance of prostaglandin-induced iris pigmentation
26. Prostaglandin derivative devoid of side effects for the treatment of glaucoma
27. 2α analogue
28. 2 on the configuration of normal human melanocytes in vitro
29. 2 receptors
30. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension
31. 2 receptor
32. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins
33. 2
34. AGN 192093: A novel thromboxane A2 mimetic with activity consistent with human thromboxane receptor heterogeneity
35. Intraocular pressure effects of selective prostanoid receptor agonists involve different receptor subtypes according to radioligand binding studies
36. The molecular biology and ocular distribution of prostanoid receptors
37. Iris-color change developed after topical isopropyl unoprostone treatment